SCHEMBL5577992

SCHEMBL5577992

CC(C)(C)OC(=O)NCC(=O)Nc1ccc(-c2cncn2-c2n[nH]c3nc(NC(=O)C4CC4)sc23)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SUV39H2 Q9H5I1 2/20 0.38
EGFR P00533 1/20 0.38
AURKB Q96GD4 1/20 0.38
MET P08581 1/20 0.35
CCNE1 P24864 2/20 0.35
CDK2 P24941 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CCNB2 O95067 1/20 0.35
CCNE2 O96020 1/20 0.35
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCND1 P24385 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABL1 P00519 2/20 0.34
PDGFRB P09619 1/20 0.34
SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578003 0.92 IDO1 (0.37) CCNE1CDK2MEN1KMT2AALDH1A1
SCHEMBL14454967 0.86 MEN1 (0.38) CCNE1CDK2MEN1KMT2ASMN1; SMN2
SCHEMBL14454919 0.85 PDK2 (0.36) EGFRMEN1KMT2AALDH1A1ABL1
SCHEMBL14454913 0.85 ABL1 (0.42) MEN1KMT2AALDH1A1SMN1; SMN2ABL1
SCHEMBL14454968 0.84 MEN1 (0.40) CCNE1CDK2MEN1KMT2AALDH1A1
SCHEMBL14454914 0.83 MEN1 (0.39) CCNE1CDK2MEN1KMT2ASMN1; SMN2
SCHEMBL5578089 0.83 CLK1 (0.36) MEN1KMT2AALDH1A1ABL1BRAF
SCHEMBL14531234 0.81 MEN1 (0.35) SUV39H2CCNE1CDK2MEN1KMT2A
SCHEMBL14454935 0.81 CASP3 (0.45) MEN1KMT2AABL1
SCHEMBL14454916 0.81 NPC1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 SUV39H2 3037/4885EGFR 603/4885AURKB 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.